Emma Groarke: Evidence-Based Guidelines for the Management of Acquired Aplastic Anemia
Emma Groarke, Associate Research Physician at the National Institutes of Health, shared American Society of Hematology’s post on LinkedIn:
“Excited to see these finally come to fruition!
We hope these will be helpful to patients and physicians dealing with aplastic anemia.
Was amazing to be part of this diverse guidelines panel of hematologists, transplanters, pediatricians, statisticians, methodologists, and of course patients.
Also the excellent ASH staff!
Special thanks to Phillip Scheinberg for taking this to ASH initially and driving it forward.”
American Society of Hematology shared a post on LinkedIn:
“ASH has released new clinical practice guidelines on the diagnosis and management of severe and very severe acquired aplastic anemia, a rare and life-threatening bone marrow disorder.
Developed by a multidisciplinary panel that included a patient perspective, these evidence-based recommendations are designed to support earlier and more accurate diagnosis, guide treatment decisions, and improve outcomes for children and adults living with this condition.
Learn more in the press release.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 28, 2026, 15:00Rucha Patil: Grateful to Contribute to the National Coagulation Conclave 2026
-
Jul 28, 2026, 14:51Islam Aboumoussa: A New Perspective on Dual Antithrombotic Therapy in Stroke Prevention
-
Jul 28, 2026, 14:40Marilena Vrana: Join the Conversation at Plasma Protein Forum 2026
-
Jul 28, 2026, 14:24Jon Wright: Pushing the Boundaries of Hemophilia Care
-
Jul 28, 2026, 14:11Improving Care for People with Bleeding Disorders Through Teamwork – WFH
-
Jul 28, 2026, 14:10Blessing Oluwasanya: When Heavy Periods Are More Than Just an Inconvenience
-
Jul 28, 2026, 13:46Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
-
Jul 28, 2026, 13:22Raelene Kambli: Advocating for Safer Blood Access
-
Jul 28, 2026, 13:07Connie Montgomery: Conversations That Change Hemophilia Care